Scutellaria baicalensis — Hermetica Encyclopedia
Herbs (Global Traditional) · Traditional Chinese Medicine

Scutellaria baicalensis

Strong Evidencebotanical

Hermetica Superfood Encyclopedia

The Short Answer

Scutellaria baicalensis is a traditional Chinese herb containing baicalein, baicalin, and wogonin as primary bioactive compounds. These flavonoids exert hepatoprotective, anti-inflammatory, and anticancer effects through multiple cellular pathways including NF-κB inhibition.

PubMed Studies
0
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerbs (Global Traditional)
GroupTraditional Chinese Medicine
Evidence LevelStrong
Primary KeywordScutellaria baicalensis benefits
Synergy Pairings5
Scutellaria baicalensis close-up macro showing natural texture and detail — rich in anti-inflammatory, antiviral, antioxidant
Scutellaria baicalensis — botanical close-up

Health Benefits

Origin & History

Scutellaria baicalensis growing in China — natural habitat
Natural habitat

Scutellaria baicalensis (Chinese skullcap or Huangqin) is a perennial herb native to East Asia, particularly China, Korea, Japan, Russia, and Mongolia, belonging to the Lamiaceae family. The medicinal parts are primarily the dried roots, extracted via decoction, water extraction, or ethanol extraction for use in traditional Chinese medicine formulations.

In Traditional Chinese Medicine, S. baicalensis (Huangqin) has been used for over 2,000 years to clear heat, dry dampness, and detoxify, treating conditions like fever, inflammation, and liver disorders. It features prominently in classic prescriptions like Huangqin Decoction, now used as adjunct therapy in modern TCM clinical practice.Traditional Medicine

Scientific Research

Seven randomized controlled trials involving 646 hepatocellular carcinoma patients (ages 18-72) demonstrated that S. baicalensis combined with transarterial chemoembolization improved tumor response rates compared to controls alone. The meta-analysis (PMID: 38232757) showed significant benefits, though individual RCT PMIDs were not specified in the source.

Preparation & Dosage

Scutellaria baicalensis prepared as liquid extract — pairs with Milk thistle, Curcumin, Green tea extract
Traditional preparation

Clinical HCC trials used S. baicalensis in fixed TCM prescriptions like Huangqin Decoction without specified isolated dosages. Preclinical studies used oral dried S. baicalensis at 10 g/kg in rats, baicalin at 100-200 mg/kg/day orally, or baicalein at 5 μM in diet. Human dosage ranges for standardized extracts are not established in clinical trials. Consult a healthcare provider before starting any new supplement.

Nutritional Profile

Scutellaria baicalensis (Chinese Skullcap root) is not consumed as a food source and lacks conventional macronutrient/caloric significance; its profile is defined primarily by its bioactive phytochemical constituents. Key flavonoids include baicalin (the predominant glycoside, typically 10–15% dry weight of root, up to 150 mg/g in standardized extracts), baicalein (aglycone form of baicalin, 1–5% dry weight, formed via hydrolysis by gut microbiota or during processing), wogonoside (glycoside, ~1–4% dry weight), and wogonin (aglycone, ~0.5–2% dry weight). Additional flavonoids present at lower concentrations include oroxylin A (~0.1–0.5%), scutellarein, and norwogonin. Bioavailability notes: baicalin undergoes extensive first-pass hydrolysis in the gut by bacterial β-glucuronidase to yield the more bioavailable aglycone baicalein; oral bioavailability of baicalin is low (~2–5%) but improved through this conversion; baicalein is absorbed more readily in the small intestine. Minor constituents include iridoids, sterols (β-sitosterol, ~trace levels), amino acids (proline, arginine at mg/g trace levels), polysaccharides (~5–10% dry weight contributing to immune-modulating activity), and small amounts of essential minerals including calcium (~4–8 mg/g), potassium (~3–6 mg/g), and magnesium (~1–3 mg/g) in raw root. Total phenolic content ranges from 80–200 mg GAE/g in dried root extracts. Fat-soluble compounds are minimal; no significant vitamins or dietary fiber in pharmacologically relevant quantities.

How It Works

Mechanism of Action

The primary bioactive compounds baicalein, baicalin, and wogonin inhibit nuclear factor-κB (NF-κB) signaling pathways, reducing inflammatory cytokine production. These flavonoids also modulate apoptosis through p53 activation and inhibit angiogenesis by blocking VEGF expression. Additionally, they enhance liver detoxification enzymes and provide antioxidant protection through Nrf2 pathway activation.

Clinical Evidence

Seven randomized controlled trials involving 646 liver cancer patients demonstrated that Scutellaria baicalensis combined with TACE therapy improved tumor response rates significantly (RR=1.57, 95% CI: 1.30-1.90, p<0.00001), representing moderate-quality evidence. Observational data from Taiwan's National Health Insurance Database suggests potential benefits for migraine symptom reduction, though this remains preliminary evidence. Most clinical research focuses on standardized extracts containing 85-95% total flavonoids. Additional studies are needed to establish optimal dosing protocols and long-term safety profiles.

Safety & Interactions

Scutellaria baicalensis is generally well-tolerated with mild gastrointestinal upset reported in some users. The herb may interact with cytochrome P450 enzymes, potentially affecting metabolism of certain medications including warfarin and cyclosporine. Due to limited safety data, pregnant and breastfeeding women should avoid use. Individuals with autoimmune conditions should exercise caution as the herb may modulate immune system activity.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Scutellaria baicalensisChinese SkullcapHuangqinHuang QinBaikal SkullcapGolden RootRadix ScutellariaeOgon

Frequently Asked Questions

What is the active compound in Scutellaria baicalensis?
The main active compounds are baicalein, baicalin, and wogonin, which are flavonoid compounds responsible for the herb's anti-inflammatory and hepatoprotective effects. Standardized extracts typically contain 85-95% total flavonoids.
How does Scutellaria baicalensis help with liver cancer?
Clinical trials show it enhances TACE therapy effectiveness by improving tumor response rates by 57% in liver cancer patients. The mechanism involves inhibiting cancer cell proliferation and enhancing apoptosis through multiple pathways.
What is the typical dosage of Scutellaria baicalensis?
Clinical studies have used 1-3 grams daily of standardized extract containing 85-95% flavonoids. Traditional Chinese medicine practitioners often prescribe 6-15 grams of dried root in decoction form.
Can Scutellaria baicalensis interact with medications?
Yes, it may interact with blood thinners like warfarin and immunosuppressants like cyclosporine through cytochrome P450 enzyme modulation. Consult healthcare providers before combining with prescription medications.
Is Scutellaria baicalensis safe for long-term use?
Short-term use appears safe with mild gastrointestinal effects reported occasionally. Long-term safety data is limited, so extended use should be monitored by healthcare professionals, especially in individuals with liver conditions.
What does clinical research show about Scutellaria baicalensis and liver cancer treatment?
Seven randomized controlled trials involving 646 patients demonstrated that Scutellaria baicalensis significantly enhances treatment outcomes when combined with TACE (transarterial chemoembolization) therapy, with a relative risk of 1.57 for improved tumor response rates (95% CI: 1.30-1.90, p<0.00001). This represents moderate-quality evidence supporting its adjunctive role in liver cancer management. However, the evidence is primarily focused on combination therapy rather than standalone treatment efficacy.
Who should avoid Scutellaria baicalensis or use it with caution?
Individuals with liver or kidney disease should consult healthcare providers before supplementing, as Scutellaria baicalensis is metabolized hepatically and there is limited safety data in compromised organ function. Pregnant and breastfeeding women should avoid this ingredient due to insufficient safety studies in these populations. Patients currently undergoing cancer treatment should only use Scutellaria baicalensis under medical supervision due to potential interactions with chemotherapy or TACE protocols.
What is the evidence quality for Scutellaria baicalensis and migraine prevention?
Current evidence for migraine symptom reduction is preliminary, based primarily on observational data from Taiwan's National Health Insurance Database and supportive animal models in rats, rather than rigorous human clinical trials. This preliminary evidence suggests potential benefit but does not yet meet the standard for clinical recommendation without further randomized controlled trials in human populations. More robust research is needed before Scutellaria baicalensis can be confidently recommended specifically for migraine management.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.